Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases.

Rebecca HudsonCassandra RawlingsSaw Yu MonJulia JefferisGeorge T John

Published in: BMC nephrology (2022)

Our cases add to the current limited literature on the successful use of obinutuzumab in PLA2R associated MN refractory to standard therapy including rituximab.

Keyphrases

chronic lymphocytic leukemia
systematic review
diffuse large b cell lymphoma
binding protein
bone marrow